WO2003073843A3 - Inbred embryonic stem-cell derived mice - Google Patents

Inbred embryonic stem-cell derived mice Download PDF

Info

Publication number
WO2003073843A3
WO2003073843A3 PCT/EP2003/002180 EP0302180W WO03073843A3 WO 2003073843 A3 WO2003073843 A3 WO 2003073843A3 EP 0302180 W EP0302180 W EP 0302180W WO 03073843 A3 WO03073843 A3 WO 03073843A3
Authority
WO
WIPO (PCT)
Prior art keywords
inbred
mice
embryonic stem
cell derived
derived mice
Prior art date
Application number
PCT/EP2003/002180
Other languages
French (fr)
Other versions
WO2003073843A2 (en
Inventor
Ralf Kuehn
Anja Rode
Rudolph Jaenisch
Branco Zevnik
Original Assignee
Artemis Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artemis Pharmaceuticals Gmbh filed Critical Artemis Pharmaceuticals Gmbh
Priority to AT03743372T priority Critical patent/ATE306810T1/en
Priority to EP03743372A priority patent/EP1480515B1/en
Priority to DE60301953T priority patent/DE60301953T2/en
Priority to AU2003210405A priority patent/AU2003210405A1/en
Publication of WO2003073843A2 publication Critical patent/WO2003073843A2/en
Publication of WO2003073843A3 publication Critical patent/WO2003073843A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/02—Cells from transgenic animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Abstract

An improved and reproducible method for the generation of ES mice from inbred ES cells, without the need to generate a chimeric mouse intermediate is provided. The inbred ES cells may be recombinant or genetically modified, resulting in ES mice that are transgenic. The method may also be used for the fast production of ES mice strains homozygous for a defined genetic alteration.
PCT/EP2003/002180 2002-03-05 2003-03-04 Inbred embryonic stem-cell derived mice WO2003073843A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AT03743372T ATE306810T1 (en) 2002-03-05 2003-03-04 INBREEDED EMBRYONAL STEM CELL-DERIVED MICE
EP03743372A EP1480515B1 (en) 2002-03-05 2003-03-04 Inbred embryonic stem-cell derived mice
DE60301953T DE60301953T2 (en) 2002-03-05 2003-03-04 MICE DERIVED FROM INNOVATION MALE DERIVED FROM EMBRYONIC STEM CELLS
AU2003210405A AU2003210405A1 (en) 2002-03-05 2003-03-04 Inbred embryonic stem-cell derived mice

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36216302P 2002-03-05 2002-03-05
US60/362,163 2002-03-05

Publications (2)

Publication Number Publication Date
WO2003073843A2 WO2003073843A2 (en) 2003-09-12
WO2003073843A3 true WO2003073843A3 (en) 2004-01-22

Family

ID=27789146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/002180 WO2003073843A2 (en) 2002-03-05 2003-03-04 Inbred embryonic stem-cell derived mice

Country Status (6)

Country Link
US (1) US20030204862A1 (en)
EP (1) EP1480515B1 (en)
AT (1) ATE306810T1 (en)
AU (1) AU2003210405A1 (en)
DE (1) DE60301953T2 (en)
WO (1) WO2003073843A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006044962A1 (en) 2004-10-19 2006-04-27 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
EP1999249B8 (en) * 2006-03-30 2012-02-15 The University Court Of The University of Edinburgh Culture medium containing kinase inhibitors. and uses thereof
GB0615327D0 (en) * 2006-03-30 2006-09-13 Univ Edinburgh Culture medium containing kinase inhibitors and uses thereof
WO2007127254A2 (en) * 2006-04-25 2007-11-08 President And Fellows Of Harvard College Compositions and methods for generating transgenic animals
SG10201607710UA (en) * 2008-03-17 2016-11-29 Scripps Research Inst Combined chemical and genetic approaches for generation of induced pluripotent stem cells
US9149026B2 (en) 2010-06-11 2015-10-06 Regeneron Pharmaceuticals, Inc. Production of fertile XY animals from XY ES cells
KR20140063501A (en) 2010-12-22 2014-05-27 페이트 세러퓨틱스, 인코포레이티드 Cell culture platform for single cell sorting and enhanced reprogramming of ipscs
EP2471554A1 (en) 2010-12-28 2012-07-04 Hexal AG Pharmaceutical formulation comprising a biopharmaceutical drug
EP2511293A1 (en) 2011-04-13 2012-10-17 LEK Pharmaceuticals d.d. A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins
CU24312B1 (en) 2013-07-23 2018-02-08 Biocon Ltd METHODS TO CONTROL FUCOSILATION LEVELS IN PROTEINS
EP3604499A1 (en) 2014-03-04 2020-02-05 Fate Therapeutics, Inc. Improved reprogramming methods and cell culture platforms
DK3161128T3 (en) 2014-06-26 2018-11-05 Regeneron Pharma METHODS AND COMPOSITIONS FOR TARGETED GENTICAL MODIFICATIONS AND PROCEDURES FOR USE THEREOF
RU2729407C1 (en) 2015-09-17 2020-08-06 Регенерон Фармасьютикалз, Инк. Selection of pluripotent cells for producing fertile xy female mice
JP7263005B2 (en) 2015-10-16 2023-04-24 フェイト セラピューティクス，インコーポレイテッド A platform for the induction and maintenance of ground-state pluripotency
EP3403649A1 (en) 2017-05-16 2018-11-21 Bayer Pharma Aktiengesellschaft Inhibitors and antagonists of gpr84 for the treatment of endometriosis
EP3406253A1 (en) 2017-05-24 2018-11-28 Bayer Aktiengesellschaft Inhibitors and antagonists of human pycr1
WO2019081456A1 (en) 2017-10-24 2019-05-02 Bayer Aktiengesellschaft Use of activators and stimulators of sgc comprising a beta2 subunit
EP3801613A1 (en) 2018-06-04 2021-04-14 Bayer Aktiengesellschaft Inhibitors of shp2
KR102398485B1 (en) 2019-02-18 2022-05-16 에이티비 테라퓨틱스 Methods of Production of Binder-Toxin Fusion Proteins in Plant Cells or Whole Plants
EP3946416A2 (en) 2019-04-04 2022-02-09 Bayer Aktiengesellschaft Agonists of adiponectin
SG11202109901TA (en) 2019-04-09 2021-10-28 Hospital For Special Surgery Protein binders for irhom2
AU2020360849A1 (en) 2019-09-30 2022-04-14 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Protein binders to iRhom2 epitopes
EP4069301A1 (en) 2019-12-04 2022-10-12 Bayer Aktiengesellschaft Inhibitors of shp2
CA3187245A1 (en) 2020-08-17 2022-02-24 Sebastien Mercx Recombinant immunotoxin comprising a ribotoxin or rnase
KR20230150287A (en) 2021-02-26 2023-10-30 바이엘 악티엔게젤샤프트 Inhibitors of IL-11 or IL-11RA for use in the treatment of abnormal uterine bleeding
BR112023017035A2 (en) 2021-03-01 2024-02-06 New York Soc For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surger HUMANIZED ANTIBODIES AGAINST IRHOM2, NUCLEIC ACID, USE OF THE ANTIBODY, PHARMACEUTICAL COMPOSITION, COMPOSITION, TREATMENT METHOD AND THERAPEUTIC KIT
CA3213771A1 (en) 2021-03-29 2022-10-06 Scirhom Gmbh Methods of treatment using protein binders to irhom2 epitopes
US20230190807A1 (en) 2021-10-06 2023-06-22 Immatics Biotechnologies Gmbh Tcr compounds, compositions, and methods of treating
US20230192886A1 (en) 2021-11-08 2023-06-22 Immatics Biotechnologies Gmbh Adoptive cell therapy combination treatment and compositions thereof
WO2023156634A1 (en) 2022-02-17 2023-08-24 Atb Therapeutics Recombinant immunotoxin comprising a ribosome inactivating protein
WO2024023246A1 (en) 2022-07-28 2024-02-01 Philogen S.P.A. Antibody binding to pd1
WO2024033362A1 (en) 2022-08-08 2024-02-15 Atb Therapeutics Humanized antibodies against cd79b

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015764A2 (en) * 1998-09-11 2000-03-23 University Of Edinburgh Propagation and/or derivation of embryonic stem cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015764A2 (en) * 1998-09-11 2000-03-23 University Of Edinburgh Propagation and/or derivation of embryonic stem cells

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BURDON T ET AL: "SUPPRESSION OF SHP-2 AND ERK SIGNALLING PROMOTES SELF-RENEWAL OF MOUSE EMBRYONIC STEM CELLS", DEVELOPMENTAL BIOLOGY, ACADEMIC PRESS, NEW YORK, NY, US, vol. 210, 1 June 1999 (1999-06-01), pages 30 - 43, XP000901724, ISSN: 0012-1606 *
EGGAN KEVIN ET AL: "Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 98, no. 11, 22 May 2001 (2001-05-22), pages 6209 - 6214, XP002206043, ISSN: 0027-8424 *
NAGY A ET AL: "DERIVATION OF COMPLETELY CELL CULTURE-DERIVED MICE FROM EARLY-PASSAGE EMBRYONIC STEM CELLS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 90, September 1993 (1993-09-01), pages 8424 - 8428, XP002938900, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
ATE306810T1 (en) 2005-11-15
US20030204862A1 (en) 2003-10-30
WO2003073843A2 (en) 2003-09-12
AU2003210405A1 (en) 2003-09-16
DE60301953T2 (en) 2006-07-27
EP1480515A2 (en) 2004-12-01
EP1480515B1 (en) 2005-10-19
DE60301953D1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
WO2003073843A3 (en) Inbred embryonic stem-cell derived mice
DK0843961T3 (en) Chimeric mouse and method of producing same
WO2003102201A3 (en) Methods and materials for the production of d-lactic acid in yeast
AU2002309510A1 (en) Method for modifying plant biomass
ATE426661T1 (en) SOMATIC PLURIPOTENT CELLS
WO2003100013A3 (en) NON-REVERTIBLE β-OXIDATION BLOCKED CANDIDA TROPICALIS
WO2003049525A3 (en) Methods and materials for the production of organic products in cells of $i(candida) species
DK0972445T3 (en) Chimeric mouse expressing a human antibody
FI950277A0 (en) Production of xenogenic antidotes
WO2002042471A3 (en) Methods and materials for the synthesis of organic products
DK1297172T3 (en) Methods for Generating Modified Glucoproteins
WO2009071334A3 (en) Transposon-mediated mutagenesis in spermatogonial stem cells
JP2009509556A5 (en)
NZ514025A (en) Compositions and methods for the modification of gene transcription
MX2008000200A (en) Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof.
WO2003054189A3 (en) Methods for the transformation of vegetal plastids
ATE513049T1 (en) SITE DIRECTED TRANSFORMATION USING AMPLIFICATION VECTORS
ATE541033T1 (en) METHOD FOR PRODUCING CELLULASE AND HEMICELLULASE WITH HIGH HYDROLYSIS ACTIVITY
WO2008150463A8 (en) Use of genetically modified organisms to generate biomass degrading enzymes
DE60223377D1 (en) MODIFICATION OF MUSHROOMS USING L-ARABINOSE
WO2006108882A8 (en) In vitro production of a cell population using feeder cells
WO2002010337A3 (en) Method of cloning porcine animals
WO2002068635A3 (en) Methods of inhibiting expression of a target gene in mammalian cells
AU2001226023A1 (en) A method for generating hypermutable plants
DK1021552T3 (en) Transgenic Lemnaceae

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003743372

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003743372

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2003743372

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP